News Center
Press Releases
- Olympus Supports Safety Actions from The Joint Commission Regarding Hazardous Gases and Vapors in the O.R. April 8, 2021
- Olympus Westborough Celebrates Virtual Grand Opening April 7, 2021
- Live Webinar: Reimagining the Clinical Space Using Virtual Technologies April 7, 2021
- Olympus Files Patent Infringement Lawsuit Against Cantel/Medivators March 25, 2021
- FDA Clears Olympus’ Narrow Band Imaging® (NBI) for Use in Assessing Colonic Lesions March 15, 2021
- Olympus Launches Awareness Initiatives in Support of Colorectal Cancer Awareness Month March 5, 2021
- Olympus Exercises Option to Buy Israeli Medical Device Company Medi-Tate to Drive Global Urology Business Growth February 26, 2021
- Even Before COVID-19, 24% Reported Putting Off Their Colonoscopy February 19, 2021
- Olympus Partners with Imbio to Bring AI-based Patient Selection Tools to Customers with SeleCT™ QCT Analysis Service February 16, 2021
- Live Remote Supervision of Neuroendovascular Surgery Enabled by Olympus MedPresence® February 11, 2021
Olympus Responds
to COVID-19
Olympus is monitoring the novel coronavirus situation, in accordance with its mission of making people’s lives healthier, safer and more fulfilling around the world.
Contact Media Relations
Corporate Inquiries:
Stephanie Sherry
Vice President, Corporate Communications
Direct: (484) 896-5206
Cell: (484) 241-6465
stephanie.sherry@olympus.com
Medical and Surgical Inquiries:
Jennifer Bannan
Direct: (484) 896-6170
Cell: (412) 403-8742
jennifer.bannan@olympus.com
Scientific Solutions Inquiries:
Hilary Banda
Direct: (781) 419-3624
Cell: (339) 368-2742
hilary.banda@olympus-ossa.com
